CompletedPhase 2NCT03166189
Autologous Bone Marrow-derived Mesenchymal Stem Cells for Atrophic Endometrium in Patients With Repeated IVF Failures
Studying Asherman syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
- Principal Investigator
- Alexandr Gzgzyan, Prof, PhDD.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
- Intervention
- bone marrow-derived MSC and HRT(biological)
- Enrollment
- 46 enrolled
- Eligibility
- 21-44 years · FEMALE
- Timeline
- 2017 – 2019
Study locations (1)
- D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology, Saint Petersburg, Russia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03166189 on ClinicalTrials.govOther trials for Asherman syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGEARLY PHASE1NCT05343572Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal EndometriumHugh Taylor
- ENROLLING BY INVITATIONNANCT06608407Platelet Rich Plasma in the Prevention of Adhesion ReformationFu Xing Hospital, Capital Medical University
- ACTIVE NOT RECRUITINGNANCT04963179PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.Womed
- RECRUITINGPHASE4NCT04671914Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester.Institute for the Care of Mother and Child, Prague, Czech Republic